Inclusion Criteria:
Patients > 18 years of age Patients planning to start treatment with cabozantinib therapy for renal cancer.
Technology requirement: The patient will need to have home wireless internet access for use of the software and technology in this study. The patient will need to already have or be willing to set up a Duke MyChart account.
Exclusion Criteria:
Non-English Speaking. Any patient who is not able to comprehend and operate the technology at the discretion of the enrolling provider.
